/
Infectious Disease
Herpes Zoster
16
Pipeline Programs↗
35
Active Trials↗
25
Companies Involved↗
Herpes Zoster is an emerging landscape with 16 programs across 25 companies. The most active players are Immorna Biotherapeutics, Inc., Shenzhen Shenxin Biotechnology Co., Ltd, Suzhou Abogen Biosciences Co., Ltd.. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical10
Phase 23
Phase 32
Approved
No programs
Analysis
Modality Breakdown
77%
Small molecule
10 of 13 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 13 classified programs, each share of the total. Modality classified for 100% of 16 pipeline programs.
Analysis
Trial Status
109
clinical trials
Completed61 · 56%
Recruiting17 · 16%
Active, not recruiting11 · 10%
Not yet recruiting7 · 6%
Unknown status7 · 6%
Terminated5 · 5%
Other1 · 1%
Clinical Trials
Trial Activity
109 trials
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07307170·750 enrolled
Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
Recruiting·—·Phase 2·NCT06978192·92 enrolled
The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07370389·750 enrolled
The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07361809·750 enrolled
The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07307976·750 enrolled
Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia
Recruiting·—·N/A·NCT06969417·50 enrolled
High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia
Recruiting·—·Phase 4·NCT06959147·46 enrolled
The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster
Recruiting·—·N/A·NCT07378046·750 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)